The idea of creating Cerebrum Matter stems from our founder’s personal experience of accompanying her grandmother through a rough journey with Parkinson’s, a decade ago.
Our idea of digital healthcare came to the fore in 2016 when the company’s bootstrapping stage, leading to the idea of a therapy software highly focused on dementia symptoms. The development of the software tunnelled into the R&D process by end of 2017, leading us to start working on conducting a clinical trial with people to develop an evidence-based product aiming sincerely at treating cognitive declination, depression, anger & anxiety, the logical reasoning which are considered to leading onset symptoms of dementia using brainwave analysis.
Dementia is the broad category of neurodegenerative brain diseases that includes such diseases as Alzheimer’s, vascular dementia and Lewy body dementia, etc.
While the use of medication is undoubtedly vital in helping both severe and light sufferers of dementia, Cerebrum Matter believes that dementia prevention is still an underdeveloped form of treatment that could potentially change the way the earlier stages of dementia are treated.
With our advanced brainwave technology we are aiming to provide a personalised experience of cognitive improvement according to each individuals’ brain functionalities.
Changing the Game for Healthy
Cerebrum Matter Founded
COSMA development + Clinical trials
COSMA Soft Launch
Neurofeedback Europe Launch
Cerebrum Matter Active
Neurofeedback Headset Development
Neurofeedback CE Approved
To prevent and reduce the prevalence of the symptoms of early onset dementia, by promoting mental wellness and thus leading to longer and higher quality independent lives to the elderly.
To become a Global leader in the field of cognitive therapy focused brainwave technology, leading to a significant reduction in the estimated numbers of future potential victims of dementia.
Meet the Team
Miss Kartheka Bojan, Founder & CEO of Cerebrum Matter Ltd, a digital healthcare
In her role as Chief Medical Engineer at her previous employment, she designed a Nanotechnology-based Non-Invasive Continuous Glucose Monitoring Device. She is the author of pending patents in EEG technology for Alzheimer’s & a Glucose Monitoring device and has also published work on Design of Biosensors with Gold Nanoparticles.
The idea of creating Cerebrum Matter stems from her personal experience of accompanying her grandmother through a rough journey with Parkinson’s, a decade ago. Her vision to treat early onset dementia through digital therapy has been transformed into Cerebrum Matter’s mission to reduce the prevalence of disabling symptoms for people living with dementia.
Andrew Perkins has 10 years’ experience in the finance sector and a certified accountant
Andrews core values are based on accountability and integrity with an entrepreneurial, strategic focus.
Driving growth at a digital asset exchange while ensuring a focus on revenue-generating products through implementing robust forecasting capability. Ensuring a culture of control and improving management information.
Prof. Mukaetova-Ladinska is chairman of Old Age Psychiatry, University of Leicester
Dr Elizabeta Mukaetova-Ladinska is the lead investigator on an Alzheimer’s Society-funded study, entitled ‘Blood Markers in Dementia Study’. The potential outcome would be to develop an inexpensive yet accurate test that could differentiate between Alzheimer’s disease and other forms of dementia, such as dementia with Lewy bodies and vascular dementia.
Adnan is the Quality, Regulatory & Validation Specialist with over 19 years of exp
His expertise is more towards Medical Device regulations and Pharma Industry. He is well updated with all the MDR and new regulatory policies both in Europe and USA. Adnan is responsible for all the regulatory pathway and direction of CM’s all products.
Ramana is the Founder and President of California USA based 3S Ventures;
Ramana has access to experts and senior leaders in the industry in USA, Europe, Middle East, India and Latin America. Many of these experts are formal consulting partners of 3S Ventures.
Ramana is a partner at Bridege4Bio, a California based consulting company that is involved in product development and global commercialization of Life Science products. Ramana is advisor and associate at One Rock Capital Partners, Ramana is also associated with Shoreview Capital, a St.Paul/ Minneapolis USA based Private Equity Fund and advices on Healthcare acquisitions.
Business Development Advisor
As a seasoned executive with over 25 years of international industry experience
After a global tenure at IBM he has been involved in a number of start-ups and innovation programs, The emerging Blockchain technology, AI & Robotica have caught his interest as the next game changers in building sustainable businesses with societal impact.